News

Conservatives skewered an online photo of liberal megadonor Alex Soros and former Hillary Clinton aide Huma Abedin. An article from The New Yorker went viral on Monday for showcasing notable New ...
Alex Palou won from pole Sunday at Barber Motorsports Park by more than 16 seconds, giving the Chip Ganassi Racing driver three wins in four starts this season. I mean…could you blame him?
Medtronic is seeking regulatory clearance for an insulin pump that could expand its partnership with Abbott. In its application to the Food and Drug Administration, Medtronic is seeking clearance ...
Alex the Great is back at the ballpark and making waves once again. The 4-year-old Flemish Giant Rabbit, who made a fan out of Grammy-winning singer Chappell Roan after going viral multiple times ...
Medtronic’s top ventilator executive began ... high-flow nasal cannulas delivering oxygen through the nose, said Dr. Alex Teeters, pulmonary and critical care physician at Allina Health.
Medtronic PLC’s stock fell 7.3% as the worst performer in the S&P 500 on Tuesday after the medical-products company’s earnings fell slightly short of Wall Street’s revenue target despite a ...
VCG / Contributor / Getty Images Medtronic shares slumped Tuesday after the medical device maker missed sales forecasts. The revenue miss came as sales of its stapling and blood oxygen management ...
Medtronic Q3 revenue of $8.29 billion missed estimates, but EPS of $1.39 beat the $1.36 consensus. Medtronic reaffirms FY25 organic growth guidance of 4.75%-5%. Get 5 ...
Medtronic (NYSE: MDT) reported its Q2 fiscal 2025 results (fiscal ends in April) last week, with revenues and earnings exceeding the street estimates. The company reported revenue of $8.4 billion ...
Medical leaders Medtronic and Abbott are collaborating on diabetes care in a new partnership that will combine technologies to expand options for patients. Medtronic is known for insulin pumps ...
Medtronic beat on sales and earnings and gave exactly the guidance that Wall Street expected. Its stock dropped today anyway. Why? Because Medtronic stock costs too much. Heading into earnings ...
Medtronic said Friday that the U.S. Food and Drug Administration has approved a new spinal-cord implant that relieves chronic pain, a bid to expand into a patient population that relies heavily on ...